Human lung adenosquamous carcinoma PD1 antibody acquired drug-resistant primary cell strain and application thereof
The invention relates to the technical field of cell biology, in particular to a human lung adenosquamous carcinoma PD1 antibody acquired drug-resistant primary cell strain and application thereof. A PD1 expression positive (35%) adenosquamous carcinoma patient is selected and subjected to four time...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
28.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!